Immunic, Inc. Operating Lease Right-of-Use Assets
Immunic, Inc. (IMUX) had Operating Lease Right-of-Use Assets of $565.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-11
- 2026-06-30: Operating Lease, Right-of-Use Asset $565.00K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $417.00K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $575.00K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $791.00K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $565.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $417.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $575.00K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $791.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $975.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $968.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $991.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $878.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $928.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.10M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $1.30M 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.41M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.85M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $1.96M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.55M 10-K · filed 2024-02-22 |
| 2022-09-30 | $1.26M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $745.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $874.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $948.00K 10-K · filed 2023-02-23 |
| 2021-09-30 | $1.05M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.17M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $1.24M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $901.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | $940.00K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $996.00K 10-Q · filed 2020-08-03 |
| 2020-03-31 | $604.00K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $633.00K 10-K · filed 2021-02-26 |
| 2019-09-30 | $71.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $68.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $12.00K 10-Q · filed 2019-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |